Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Companion Diagnostics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 9.8% during the forecast period.
This report presents the market size and development trends by detailing the Companion Diagnostics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Companion Diagnostics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Companion Diagnostics industry and will help you to build a panoramic view of the industrial development.
Companion Diagnostics Market, By Type:
Polymerase Chain Reaction Test ( PCR)
Immunohistochemistry Test (IHC)
In Situ Hybridization Test (ISH)
Others
Companion Diagnostics Market, By Application:
Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Melanoma
Others
Some of the leading players are as follows:
QIAGEN N.V.
Covance
Illumina
Siemens Healthineers.
Takeda.
Thermo Fisher Scientific Inc
Myriad Genetics Inc
Roche Diagnostics
Abbott Laboratories
Tocagen
QIAGEN NV
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Companion Diagnostics Market: Technology Type Analysis
-
4.1 Companion Diagnostics Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Companion Diagnostics Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Polymerase Chain Reaction Test ( PCR)
4.3.2 Immunohistochemistry Test (IHC)
4.3.3 In Situ Hybridization Test (ISH)
4.3.4 Others
5 Companion Diagnostics Market: Product Analysis
-
5.1 Companion Diagnostics Product Market Share Analysis, 2018 & 2026
-
5.2 Companion Diagnostics Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Companion Diagnostics Market: Application Analysis
-
6.1 Companion Diagnostics Application Market Share Analysis, 2018 & 2026
-
6.2 Companion Diagnostics Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Lung Cancer
6.3.2 Breast Cancer
6.3.3 Colorectal Cancer
6.3.4 Leukemia
6.3.5 Melanoma
6.3.6 Others
7 Companion Diagnostics Market: Regional Analysis
-
7.1 Companion Diagnostics Regional Market Share Analysis, 2018 & 2026
-
7.2 Companion Diagnostics Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 QIAGEN N.V.
9.1.1 QIAGEN N.V. Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Covance
9.2.1 Covance Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Illumina
9.3.1 Illumina Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Siemens Healthineers.
9.4.1 Siemens Healthineers. Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Takeda.
9.5.1 Takeda. Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Thermo Fisher Scientific Inc
9.6.1 Thermo Fisher Scientific Inc Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Myriad Genetics Inc
9.7.1 Myriad Genetics Inc Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Roche Diagnostics
9.8.1 Roche Diagnostics Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Abbott Laboratories
9.9.1 Abbott Laboratories Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Tocagen
9.10.1 Tocagen Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 QIAGEN NV
9.11.1 QIAGEN NV Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
The List of Tables and Figures (Totals 64 Figures and 141 Tables)
Figure Polymerase Chain Reaction Test ( PCR) Companion Diagnostics market, 2015 - 2026 (USD Million)
Figure Immunohistochemistry Test (IHC) Companion Diagnostics market, 2015 - 2026 (USD Million)
Figure In Situ Hybridization Test (ISH) Companion Diagnostics market, 2015 - 2026 (USD Million)
Figure Others Companion Diagnostics market, 2015 - 2026 (USD Million)
Figure Lung Cancer market, 2015 - 2026 (USD Million)
Figure Breast Cancer market, 2015 - 2026 (USD Million)
Figure Colorectal Cancer market, 2015 - 2026 (USD Million)
Figure Leukemia market, 2015 - 2026 (USD Million)
Figure Melanoma market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Companion Diagnostics market, by country, 2015 - 2026 (USD Million)
-
Table North America Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table North America Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table North America Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Canada Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Canada Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Europe Companion Diagnostics market, by country, 2015 - 2026 (USD Million)
-
Table Europe Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Europe Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Europe Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Germany Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Germany Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table France Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table France Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Italy Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Italy Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Spain Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Spain Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Companion Diagnostics market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table China Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table China Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Japan Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Japan Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table India Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table India Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Companion Diagnostics market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table MEA Companion Diagnostics market, by country, 2015 - 2026 (USD Million)
-
Table MEA Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table MEA Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table MEA Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Companion Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Companion Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Companion Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table QIAGEN N.V. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Covance Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Illumina Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Siemens Healthineers. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Takeda. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Thermo Fisher Scientific Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Myriad Genetics Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Roche Diagnostics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Tocagen Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table QIAGEN NV Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
